Results
1 -
10 of
47Ronald Orth, Thomas Böttcher and Stephan A. Sieber.
The biological targets of acivicin inspired 3-chloro- and 3-bromodihydroisoxazole scaffolds, Chem. Commun., 2010, 46, 8475. William P. Heal, T. H. Tam Dang and Edward W. Tate.
Activity-based probes: discovering new biology and new drug targets, Chem. Soc. Rev., 2011, 40, 246. Jérôme Clerc, Nan Li, Daniel Krahn, Michael Groll, André S. Bachmann, Bogdan I. Florea, Herman S. Overkleeft and Markus Kaiser.
The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivity, Chem. Commun., 2011, 47, 385. Bropirimine, a Small-Molecule Biological Response Modifier and an Effective Antitumor Agent, Anticancer Drug Discovery and Development: Natural Products and New Molecular Models Combined Enzymatic Degradation with Chondroitinases and Alcian Blue Precipitation in Determination of Urinary Chondroitin Sulphates, Urolithiasis and Related Clinical Research The Immunotherapy of Bladder Cancer, Immunology for Surgeons Activity-Based Protein Profiling: From Chemical Novelty to Biomedical Stalwart, Activity-Based Proteomics Credentials for Practitioners, Clinical Psychology Since 1917 Nervous tissue proteoglycans, Proteoglycans The Corresponding Committee of Fifty, 1961?1971, and the Section on Continuing Professional Education (Section 2), 1971?1986, Clinical Psychology Since 1917